Tag: Redcliffe Labs
Redcliffe Labs teams up with RGCB, to bolster single-cell genomics in...
Redcliffe Labs to operate RGCB lab with single-cell genomics and high throughput sequencing facility. This is the second genomics facility to be operated by Redcliffe Labs in India
Redcliffe Labs announces groundbreaking research on new diagnostic standards for AMH...
The research has been led by Dr Sohini Sengupta and her team of experts after analyzing nearly 2,000 samples
Redcliffe Labs partners Abbott to introduce first ever AI based clinical...
Clinical Decision Support (CDS) also known as AlinIQ, is powered by various proprietary technologies including Big Data Engines and Artificial Intelligence
Redcliffe Labs acquires Rajasthan’s largest integrated diagnostics chain Medicentre
Medicentre marks Redcliffe’s first significant acquisition as it expands its presence across India
Redcliffe Labs launches BD MAX MDR TB test for MDR-TB in...
With this new test, drug resistance against both Rifampicin and Isoniazid can be detected in a single test
Redcliffe Labs to invest $10mn for expansion of its genetics &...
As genetic tests gain popularity for diagnosis and treatment in India
Redcliffe Labs launches GENEë- a unique platform that connects clinicians directly...
The company is aiming to pave the path for affordable genetic testing and with routine diagnostics. It is also looking at opening North India’s first cutting-edge genetics laboratory in Noida
Redcliffe Labs adds Novaseq 6000 Sequencing System to its portfolio
Makes it the first in North India to house the most sophisticated sequencing system useful in the diagnosis of rare conditions in newborns, infants and in prenatal settings
Redcliffe Labs appoints Ishaan Khanna as Director-Reproductive Medicine & Genetics
Khanna's last assignment was as CEO, Biobank and Diagnostics at Lifecell where he spent over a decade
Redcliffe Labs appoints Sanjay Bhargava as its Director M&A & Growth
Bhargava comes with over 30 years of experience across different verticals of healthcare such as pharma, diagnostics, and hospitals